Avanos Medical Inc
$ 24.99
0.00%
31 Jul - close price
- Market Cap 1,170,727,000 USD
- Current Price $ 24.99
- High / Low $ 24.99 / 24.99
- Stock P/E N/A
- Book Value 16.76
- EPS -1.60
- Next Earning Report 2026-08-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.01 %
- ROE -0.09 %
- 52 Week High 25.49
- 52 Week Low 9.30
About
Avanos Medical, Inc. is a medical technology company focused on providing medical device solutions to improve the quality of life for patients in North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. The company is headquartered in Alpharetta, Georgia.
Analyst Target Price
$14.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-24 | 2025-11-05 | 2025-08-05 | 2025-05-06 | 2025-02-26 | 2024-10-30 | 2024-07-31 | 2024-05-02 | 2024-02-20 | 2023-11-01 | 2023-08-09 |
| Reported EPS | 0.22 | 0.29 | 0.22 | 0.17 | 0.26 | 0.43 | 0.36 | 0.34 | 0.19 | 0.32 | 0.3 | 0.24 |
| Estimated EPS | 0.14 | 0.25 | 0.16 | 0.15 | 0.18 | 0.3967 | 0.35 | 0.29 | 0.21 | 0.37 | 0.28 | 0.32 |
| Surprise | 0.08 | 0.04 | 0.06 | 0.02 | 0.08 | 0.0333 | 0.01 | 0.05 | -0.02 | -0.05 | 0.02 | -0.08 |
| Surprise Percentage | 57.1429% | 16% | 37.5% | 13.3333% | 44.4444% | 8.3943% | 2.8571% | 17.2414% | -9.5238% | -13.5135% | 7.1429% | -25% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-04 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.22 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AVNS
2026-07-31 13:39:58
Vanguard Capital Management has disclosed a beneficial ownership of 2,344,195 shares, representing a 5% stake in Avanos Medical Inc. This holding grants Vanguard sole voting power over 350,401 shares and sole dispositive power over all 2,344,195 shares. The shares are held by various Vanguard funds and managed accounts, benefiting from dividends and sale proceeds.
2026-07-31 05:39:58
The article focuses on the "Price to earnings forward" metric for Avanos Medical, Inc. (SWB:8HH) on the Stuttgart Stock Exchange. It provides a financial overview and notes that the market is currently closed with no trades. The article is primarily a financial data page from TradingView, offering a snapshot of the company's financial status.
2026-07-31 05:12:00
This article provides access to the "Price to earnings forward" financial metric for Avanos Medical, Inc. (LSX:A2JNRG) on the TradingView platform. It highlights that no trades occurred for this stock, and the market is currently closed. Users can find detailed financial information, documents, community insights, and technical analysis related to Avanos Medical on the platform.
2026-07-30 20:12:00
Avanos Medical (AVNS) announced on July 27, 2026, its request to the NYSE for a trading suspension and the filing of Form 25 to delist and deregister its common stock following its merger. Trading of its shares was suspended on July 27, 2026. The company plans to file Form 15 to deregister its shares and suspend SEC reporting obligations upon the effectiveness of Form 25.
2026-07-30 20:12:00
Avanos Medical has finalized new secured credit facilities totaling $775 million in term loans and a $100 million revolving credit facility, set to mature in 2033. These new facilities will support the company's take-private merger and ensure future liquidity, while simultaneously replacing its previous credit agreement with JPMorgan. The move aligns Avanos Medical's capital structure with its post-merger strategy.
2026-07-30 04:48:49
Latham & Watkins LLP advised the financing sources for American Industrial Partners' (AIP) acquisition of Avanos Medical, Inc. for approximately US$1.272 billion. The transaction involved a large legal team from Latham, providing expertise across various areas including capital markets, banking, executive compensation, data transactions, healthcare, environmental, and tax matters. This marks a significant deal for AIP, an industrials investor, in expanding its portfolio.
